Towards Next-Generation Sequencing for HIV-1 Drug Resistance Testing in a Clinical Setting
The HIV genotypic resistance test (GRT) is a standard of care for the clinical management of HIV/AIDS patients. In recent decades, population or Sanger sequencing has been the foundation for drug resistance monitoring in clinical settings. However, the advent of high-throughput or next-generation se...
Main Authors: | Calesta Hui Yi Teo, Nurul Hannah Binte Norhisham, Ogestelli Fabia Lee, Siyu Png, Chean Nee Chai, Gabriel Yan, Julian Wei-Tze Tang, Chun Kiat Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/10/2208 |
Similar Items
-
Towards next-generation sequencing for HIV-1 drug resistance testing in a clinical setting
by: Teo, Calesta Hui Yi, et al.
Published: (2023) -
Added Value of Next Generation over Sanger Sequencing in Kenyan Youth with Extensive HIV-1 Drug Resistance
by: V. Novitsky, et al.
Published: (2022-12-01) -
Next generation sequencing (NGS): a golden tool in forensic
toolkit
by: Sanaa M. Aly, et al.
Published: (2016-07-01) -
HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China
by: Miaomiao Li, et al.
Published: (2021-02-01) -
Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing
by: Cheryl Jennings, et al.
Published: (2020-12-01)